GlassScriptPhysician profile
Cheryl Rogers
NPI 1477062172
$14,759.32
in general payments reported to CMS, 2019-2025
44 companies · $2,621 in 2025
The $2,621 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,897 · 2022: $2,880 · 2023: $2,568 · 2024: $4,794 · 2025: $2,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,443 · Travel and Lodging: $1,447 · Education: $92.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,443.32 |
| Travel and Lodging | $1,447.07 |
| Education | $92.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,951.19 | 2021-2025 | Cardiomems, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $1,816.85 | 2021-2025 | Farxiga, Wainua, Lokelma |
| Novartis Pharmaceuticals Corporation | $1,283.80 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,105.70 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $1,092.51 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $771.46 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $643.32 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $588.36 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $567.33 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $552.96 | 2021-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $473.17 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Scpharmaceuticals INC. | $407.00 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $393.11 | 2021-2025 | Amvuttra, Onpattro |
| Preventric Diagnostics, INC. | $366.08 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $351.61 | 2021-2025 | Lifevest |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $283.80 | 2021-2022 | |
| Corcept Therapeutics | $259.47 | 2022-2025 | Korlym |
| Boston Scientific Corporation | $219.78 | 2022 | |
| Esperion Therapeutics, INC. | $195.59 | 2021-2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $193.84 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $193.58 | 2023-2025 | Eliquis, Camzyos |
| Axsome Therapeutics, INC. | $124.91 | 2024 | Auvelity |
| Edwards Lifesciences Corporation | $116.64 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $105.99 | 2022-2025 | Evkeeza, Praluent |
| Vifor Pharma, INC. | $105.24 | 2022-2023 | Veltassa |
| Chiesi USA, INC. | $72.78 | 2021-2024 | Cleviprex, Kengreal |
| Bridgebio Pharma, INC. | $54.07 | 2025 | Attruby |
| Analog Devices INC. | $50.00 | 2025 | Sensinel Cpm Wearable |
| Embecta Corp. | $44.91 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Surmodics, INC. | $42.20 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime Radial Access Guide Sheath |
| Lilly USA, LLC | $39.95 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $39.18 | 2024 | Arcalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $34.96 | 2024 | Fruzaqla |
| Ionis Pharmaceuticals, INC. | $25.56 | 2025 | Tryngolza |
| Inogen, INC. | $25.24 | 2025 | |
| Lantheus Medical Imaging, INC. | $24.19 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $24.19 | 2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $23.82 | 2023 | Optimizer |
| Daiichi Sankyo INC. | $23.71 | 2023 | Injectafer |
| Dexcom, INC. | $22.72 | 2021 | |
| Cequr Corporation | $18.15 | 2024 | Cequr Simplicity |
| Olympus America INC. | $15.36 | 2025 | Itind System |
| Medtronic, INC. | $11.85 | 2021 | |
| Nuwellis, INC. | $3.19 | 2024 | Aquadex Smartflow Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.